An increase in the prevalence of autoimmune disorders, a rise in the number of plasma protein therapeutics product development and surge in its adoption is expected to drive the market growth.
An increase in the prevalence of autoimmune disorders, a rise in the number of plasma protein therapeutics product development and surge in its adoption is expected to drive the market growth.